Browsing Tag
Similac
2 posts
Why Abbott Laboratories (NYSE: ABT) faces more than a legal bill after $70m Chicago baby formula ruling
Abbott was ordered to pay $70 million in a Chicago baby formula case. Read what the NEC verdict could mean for litigation risk, strategy, and ABT stock.
Abbott hit with $70m Illinois verdict in premature infant formula case
Illinois jury awards $70 million against Abbott in a premature infant NEC formula case. Read what the Cook County verdict means now.